FindTrial
Sign In

Mast Cells and Its Proteases in COPD

The Role of Mast Cells and Its Proteases in Chronic Obstructive Pulmonary Disease

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06392334
Enrollment
30
Registered
2024-04-30
Start date
2019-01-29
Completion date
2025-09-30
Last updated
2024-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD Exacerbation

Keywords

mast cell, tryptase, chymase, COPD

Brief summary

Mast cells proteases such as chymase and tryptase will be studied in the tissue of small and large airways in COPD patients

Interventions

OTHERBiopsy

Biopsy of lung tissue

Sponsors

Voronezh N.N. Burdenko State Medical Academy
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

\- COPD patients

Exclusion criteria

Other lung diseases, tumors, pregnancy \-

Design outcomes

Primary

MeasureTime frameDescription
Number of mast cells in COPD lung tissueup to 10 -12 monthsAssesment of mast cells in lung tissue in COPD patients

Countries

Russia

Contacts

Primary ContactYanina Shkatova
yankashkat@gmail.com89611875800

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026